Rabinowitz Yaron S
Ophthalmology Research, Cornea Genetic Eye Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Curr Opin Ophthalmol. 2007 Jul;18(4):279-83. doi: 10.1097/ICU.0b013e3281fc94a5.
The use of Intacs as a therapeutic modality in contact lens intolerant patients with mild to moderate keratoconus is increasingly gaining acceptance in the ophthalmic community.
During the past year we have gleaned significant new information about patients who are appropriate candidates, the location and relative placement of segment sizes and long-term safety and stability after Intacs placement. Another new and exciting development which will make this procedure safer and more commonly acceptable is the use of the femtosecond laser to create the channels to insert the Intacs, which has been described for the first time this year. This technology allows for accurate depth of inserting, improved outcomes and less complications due to superficial placement. New reports about Intacs revision surgery also allows us to retreat many patients who would otherwise have been considered surgical failures.
The new advances described this past year will improve outcomes and ultimately contribute to an increase in the amount of physicians performing this procedure and the number of patients requesting it.
对于患有轻至中度圆锥角膜且不耐受隐形眼镜的患者,使用角膜基质环(Intacs)作为一种治疗方式在眼科领域越来越被接受。
在过去一年里,我们收集到了关于哪些患者是合适的候选者、角膜基质环片段大小的位置和相对放置情况以及植入角膜基质环后的长期安全性和稳定性等重要的新信息。另一个新的、令人兴奋的进展是使用飞秒激光来制作插入角膜基质环的通道,今年首次对此进行了描述。这项技术能够实现精确的插入深度,改善治疗效果,并减少因表面放置导致的并发症。关于角膜基质环翻修手术的新报告也使我们能够对许多原本会被视为手术失败的患者进行再次治疗。
过去一年所描述的新进展将改善治疗效果,并最终促使实施该手术的医生数量以及要求进行该手术的患者数量增加。